121 related articles for article (PubMed ID: 33321661)
21. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial and anticancer activities of asymmetric lollipop-like mesoporous silica nanoparticles loaded with curcumin and gentamicin sulfate.
Cheng Y; Zhang Y; Deng W; Hu J
Colloids Surf B Biointerfaces; 2020 Feb; 186():110744. PubMed ID: 31874345
[TBL] [Abstract][Full Text] [Related]
23. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
[TBL] [Abstract][Full Text] [Related]
24. Antifungal activity of the lemongrass and clove oil encapsulated in mesoporous silica nanoparticles against wheat's take-all disease.
Sattary M; Amini J; Hallaj R
Pestic Biochem Physiol; 2020 Nov; 170():104696. PubMed ID: 32980050
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
26. Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells.
Liu Y; Chen Q; Xu M; Guan G; Hu W; Liang Y; Zhao X; Qiao M; Chen D; Liu H
Int J Nanomedicine; 2015; 10():1855-67. PubMed ID: 25834425
[TBL] [Abstract][Full Text] [Related]
27. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
[TBL] [Abstract][Full Text] [Related]
28. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
29. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
[TBL] [Abstract][Full Text] [Related]
30. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of mesoporous-silica-coated Gd2O3:Eu@silica particles as cell imaging and drug delivery agents.
Song W; Di W; Qin W
Dalton Trans; 2016 Apr; 45(17):7443-9. PubMed ID: 27040176
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of double mesoporous core-shell silica spheres with tunable core porosity and their drug release and cancer cell apoptosis properties.
El-Toni AM; Khan A; Ibrahim MA; Labis JP; badr G; Al-Hoshan M; Yin S; Sato T
J Colloid Interface Sci; 2012 Jul; 378(1):83-92. PubMed ID: 22551476
[TBL] [Abstract][Full Text] [Related]
33. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
He Y; Luo L; Liang S; Long M; Xu H
J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
[TBL] [Abstract][Full Text] [Related]
34. Preparation of iron oxide mesoporous magnetic microparticles as novel multidrug carriers for synergistic anticancer therapy and deep tumor penetration.
El-Boubbou K; Ali R; Al-Zahrani H; Trivilegio T; Alanazi AH; Khan AL; Boudjelal M; AlKushi A
Sci Rep; 2019 Jul; 9(1):9481. PubMed ID: 31263250
[TBL] [Abstract][Full Text] [Related]
35. Curcumin loaded mesoporous silica: an effective drug delivery system for cancer treatment.
Kotcherlakota R; Barui AK; Prashar S; Fajardo M; Briones D; Rodríguez-Diéguez A; Patra CR; Gómez-Ruiz S
Biomater Sci; 2016 Mar; 4(3):448-59. PubMed ID: 26674254
[TBL] [Abstract][Full Text] [Related]
36. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
Liu Q; Zhang J; Xia W; Gu H
Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
[TBL] [Abstract][Full Text] [Related]
37. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs.
Tao Z; Toms B; Goodisman J; Asefa T
ACS Nano; 2010 Feb; 4(2):789-94. PubMed ID: 20131868
[TBL] [Abstract][Full Text] [Related]
38. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
39. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
[TBL] [Abstract][Full Text] [Related]
40. Functionalized mesoporous silica nanoparticles: a possible strategy to target cancer cells reducing peripheral nervous system uptake.
Ceresa C; Nicolini G; Rigolio R; Bossi M; Pasqua L; Cavaletti G
Curr Med Chem; 2013; 20(20):2589-600. PubMed ID: 23627934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
